TY - JOUR
T1 - Cancer survivors in the workplace
T2 - sleep disturbance mediates the impact of cancer on healthcare expenditures and work absenteeism
AU - Gonzalez, Brian D.
AU - Grandner, Michael A.
AU - Caminiti, Courtney B.
AU - Hui, Siu kuen Azor
N1 - Publisher Copyright:
© 2018, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Purpose: History of cancer is significantly associated with increases in healthcare costs, worse work performance, and higher absenteeism in the workplace. This is particularly important as most cancer survivors return to employment. Sleep disturbance is a largely overlooked potential contributor to these changes. Methods: Data from 9488 state employees participating in the Kansas State employee wellness program were used to assess cancer history, sleep disturbance, healthcare expenditures, work performance ratings, and absenteeism. Participants were categorized as having had no history of breast or prostate cancer, a past history only with no current cancer treatment, or current treatment for breast or prostate cancer. Indirect mediation analyses determined whether sleep disturbance mediated the influence of cancer status on outcomes. Results: Employees receiving treatment for breast or prostate cancer had significantly greater healthcare expenditures and absenteeism than those with a past history or no history of cancer (ps <.0001). Sleep disturbance significantly mediated the impact of cancer on healthcare expenditures and absenteeism (ps <.05), accounting for 2 and 8% of the impact of cancer on healthcare expenditure and missed full days of work, respectively. Conclusions: The worse outcomes observed among employees receiving treatment for breast and prostate cancer, the most common forms of cancer among women and men, were partially explained by the impacts of cancer and treatment for cancer on sleep disturbance. These findings suggest that preventing or addressing sleep disturbance may result in economic benefits in addition to improvements in health and quality of life.
AB - Purpose: History of cancer is significantly associated with increases in healthcare costs, worse work performance, and higher absenteeism in the workplace. This is particularly important as most cancer survivors return to employment. Sleep disturbance is a largely overlooked potential contributor to these changes. Methods: Data from 9488 state employees participating in the Kansas State employee wellness program were used to assess cancer history, sleep disturbance, healthcare expenditures, work performance ratings, and absenteeism. Participants were categorized as having had no history of breast or prostate cancer, a past history only with no current cancer treatment, or current treatment for breast or prostate cancer. Indirect mediation analyses determined whether sleep disturbance mediated the influence of cancer status on outcomes. Results: Employees receiving treatment for breast or prostate cancer had significantly greater healthcare expenditures and absenteeism than those with a past history or no history of cancer (ps <.0001). Sleep disturbance significantly mediated the impact of cancer on healthcare expenditures and absenteeism (ps <.05), accounting for 2 and 8% of the impact of cancer on healthcare expenditure and missed full days of work, respectively. Conclusions: The worse outcomes observed among employees receiving treatment for breast and prostate cancer, the most common forms of cancer among women and men, were partially explained by the impacts of cancer and treatment for cancer on sleep disturbance. These findings suggest that preventing or addressing sleep disturbance may result in economic benefits in addition to improvements in health and quality of life.
KW - Absenteeism
KW - Cancer
KW - Healthcare costs
KW - Quality of life
KW - Sleep
UR - http://www.scopus.com/inward/record.url?scp=85048046655&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048046655&partnerID=8YFLogxK
U2 - 10.1007/s00520-018-4272-4
DO - 10.1007/s00520-018-4272-4
M3 - Article
C2 - 29869719
AN - SCOPUS:85048046655
SN - 0941-4355
VL - 26
SP - 4049
EP - 4055
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 12
ER -